Response to upadacitinib monotherapy in a patient with eczematid-like pigmented purpuric dermatosis

Response to upadacitinib monotherapy in a patient with eczematid-like pigmented purpuric dermatosis

Saved in:

Bibliographic Details
Main Authors:	Aditi Chokshi, DO, Anna Agaronov, DO, Uros Rakita, MD, MSc, Penelope Hirt, MD, Francisco Kerdel, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	JAAD Case Reports
Subjects:	JAK inhibitor pigmented purpuric dermatosis upadacitinib
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624004144
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Purpuric pityriasis rosea in patients with anorexia nervosa
by: Giulia Ciccarese, et al.
Published: (2025-01-01)

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01)

Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis
by: Twan Sia, BA, et al.
Published: (2025-05-01)

Refractory Chronic Hand Eczema Responds to Oral Upadacitinib
by: Nada Alghamdi, et al.
Published: (2025-01-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system
by: Yixuan Yang, et al.
Published: (2025-01-01)

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
by: Filip Van den Bosch, et al.
Published: (2025-02-01)

Dermatosis purpúrica pigmentada. A propósito de un caso con localización atípica
by: Daymí Martínez Rodríguez
Published: (2019-04-01)

A Case of Acquired Reactive Perforating Dermatosis with Complete Resolution of Eruptions on Upper and Lower Limbs During the Treatment of Diabetes Mellitus and Peripheral Artery Disease
by: Yoshihito Mima, et al.
Published: (2024-12-01)

A cross-sectional study to determine prevalence of neonatal dermatoses in a tertiary health care centre of Andhra Pradesh, South India
by: Deepti Vemu, et al.
Published: (2024-07-01)

CANDLE syndrome – a narrative review
by: Aleksandra Snopkowska, et al.
Published: (2024-09-01)

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Reflectance Confocal Microscopy of Sweet Syndrome
by: Francois Skowron, et al.
Published: (2025-01-01)

Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
by: Ji Won Heo, MD, et al.
Published: (2025-03-01)

JAK inhibitors: a new choice for diabetes mellitus?
by: Mengjun Zhou, et al.
Published: (2025-01-01)

Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro
by: Renlei Feng, et al.
Published: (2025-01-01)

Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids
by: Arun Sridhar, et al.
Published: (2025-01-01)

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
by: Elisabet Castañeda-Estévez, et al.
Published: (2024-12-01)

Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles
by: Chunying Li, et al.
Published: (2025-01-01)

Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis
by: Motoshi Sonoda, et al.
Published: (2025-01-01)

A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study
by: Yonit Wohl, et al.
Published: (2025-02-01)

Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
by: Wang Guanglian, et al.
Published: (2025-01-01)

Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages
by: Yuan Li, et al.
Published: (2024-12-01)

Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?
by: Beatrice Maranini, et al.
Published: (2025-01-01)

Vitamin A family suppresses periodontitis by restoring mitochondrial metabolic reprogramming in macrophages through JAK-STAT pathway
by: Zishuo Cheng, et al.
Published: (2025-01-01)

Clear Cell Papulosis: A Rare Pediatric Dermatosis
by: Keng Wein Jeanette Tan, et al.
Published: (2018-01-01)

Erosive Pustular Dermatosis of the Scalp with Urate-Like Crystals
by: Patrick O. Emanuel, et al.
Published: (2017-01-01)

CEACAM5 exacerbates asthma by inducing ferroptosis and autophagy in airway epithelial cells through the JAK/STAT6-dependent pathway
by: Si Liu, et al.
Published: (2025-12-01)

Ocular Involvement and Blindness Secondary to Linear IgA Dermatosis
by: Cinthya Ramos-Castellón, et al.
Published: (2010-01-01)

Folate alleviated skin inflammation and fibrosis resulting from impaired homocysteine metabolism
by: Jiefeng Huang, et al.
Published: (2025-03-01)

Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
by: Anna Roppelt, et al.
Published: (2025-01-01)

Suberosin attenuates rheumatoid arthritis by repolarizing macrophages and inhibiting synovitis via the JAK/STAT signaling pathway
by: Huan Liu, et al.
Published: (2025-01-01)

Subcorneal Pustular Dermatosis in Childhood: A Case Report and Review of the Literature
by: Massimiliano Scalvenzi, et al.
Published: (2013-01-01)

Palmoplantar plaque psoriasis responsive to upadacitinib: A report of two cases
by: Bohmyi Choi, et al.
Published: (2025-02-01)

JAK/STAT3 signaling promotes pain and depression-like behaviors in rats with bone cancer pain by regulating Th17 cell differentiation
by: Shuyan Wu, et al.
Published: (2025-02-01)

Unveiling prognostic value of JAK/STAT signaling pathway related genes in colorectal cancer: a study of Mendelian randomization analysis
by: Nan Zhang, et al.
Published: (2025-02-01)

Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation
by: Fan X, et al.
Published: (2025-02-01)

DLAT is involved in ovarian cancer progression by modulating lipid metabolism through the JAK2/STAT5A/SREBP1 signaling pathway
by: Hui Wang, et al.
Published: (2025-01-01)

Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer
by: Rui Xu, et al.
Published: (2025-01-01)